celecoxib has been researched along with Acute Kidney Injury in 18 studies
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
Excerpt | Relevance | Reference |
---|---|---|
" We evaluated rates of acute kidney injury (AKI) in primary and revision TJA using a multimodal pain control regimen including scheduled celecoxib and PRN ketorolac." | 7.83 | Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib. ( Callaghan, JJ; Hogue, MH; Klaassen, AL; Liu, SS; Noiseux, NO; Warth, LC, 2016) |
"Acute interstitial nephritis is a well-described complication of therapy with nonselective nonsteroidal anti-inflammatory drugs." | 5.31 | Celecoxib-induced acute interstitial nephritis. ( Henao, J; Hewan-Lowe, K; Hisamuddin, I; Nzerue, CM; Vasandani, G, 2002) |
" We evaluated rates of acute kidney injury (AKI) in primary and revision TJA using a multimodal pain control regimen including scheduled celecoxib and PRN ketorolac." | 3.83 | Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib. ( Callaghan, JJ; Hogue, MH; Klaassen, AL; Liu, SS; Noiseux, NO; Warth, LC, 2016) |
" Nitric oxide (NO) precursors, especially l-arginine, may have protective effects on tissue ischemia/reperfusion injury (IRI); however, their molecular mechanisms are unclear." | 3.80 | Evaluation of l-arginine on kidney function and vascular reactivity following ischemic injury in rats: protective effects and potential interactions. ( Abdel-Moneim, LM; Daabees, TT; Mohamed, HF; Omar, AG; Senbel, AM, 2014) |
"To report a case of nonoliguric acute renal failure secondary to use of celecoxib in a patient with rheumatoid arthritis." | 3.71 | Celecoxib-induced nonoliguric acute renal failure. ( Alkhuja, S; Alwarshetty, M; Ibrahimbacha, AM; Menkel, RA, 2002) |
"44 men with advanced hormoneresistant prostate cancer participated in oncologic Phase II trials." | 2.77 | Renal effects of high-dose celecoxib in elderly men with stage D2 prostate carcinoma. ( Benson, P; Chang, V; Kasimis, B; Sims, D; Srinivas, S; Yudd, M, 2012) |
"Therefore, it was considered that acute renal injury occurred from the administration of celecoxib to aged mice, whereas dry skin developed by the promotion of inflammatory cytokine secretion and release into the bloodstream in this group." | 1.72 | Effect of Celecoxib Administration on the Skin of 40-Week-Old Mice. ( Hiramoto, K; Maruyama, K; Ooi, K; Tanaka, S, 2022) |
" This may offer a novel therapeutic target for management of the adverse effect of cisplatin chemotherapy." | 1.37 | Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. ( Aoyagi, T; Jia, Z; Liu, H; Wang, H; Wang, N; Yang, T, 2011) |
" Inhibition of COX-2 has been associated with the therapeutic effects of NSAIDs, whereas inhibition of COX-1 is believed to be the cause of the adverse gastrointestinal effects associated with NSAID therapy." | 1.31 | A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. ( Arellano, FM; Lejkowith, J; Reynolds, MW; Whelton, A; Zhao, SZ, 2001) |
"Electrolyte disorders and acute renal failure are observed more frequently in patients with risk factors." | 1.31 | [Renal tolerance of selective inhibitors of cyclooxygenase type 2]. ( Deray, G, 2001) |
"Acute interstitial nephritis is a well-described complication of therapy with nonselective nonsteroidal anti-inflammatory drugs." | 1.31 | Celecoxib-induced acute interstitial nephritis. ( Henao, J; Hewan-Lowe, K; Hisamuddin, I; Nzerue, CM; Vasandani, G, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (44.44) | 29.6817 |
2010's | 9 (50.00) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Maruyama, K | 1 |
Tanaka, S | 1 |
Hiramoto, K | 1 |
Ooi, K | 1 |
Kinra, M | 1 |
Arora, D | 1 |
Mudgal, J | 1 |
Pai, KSR | 1 |
Mallikarjuna Rao, C | 1 |
Nampoothiri, M | 1 |
Senbel, AM | 1 |
Omar, AG | 1 |
Abdel-Moneim, LM | 1 |
Mohamed, HF | 1 |
Daabees, TT | 1 |
Warth, LC | 1 |
Noiseux, NO | 1 |
Hogue, MH | 1 |
Klaassen, AL | 1 |
Liu, SS | 1 |
Callaghan, JJ | 1 |
Hokuto, D | 1 |
Nomi, T | 1 |
Kawaguchi, C | 1 |
Yoshikawa, T | 1 |
Yasuda, S | 1 |
Obara, S | 1 |
Yamato, I | 1 |
Yamada, T | 1 |
Kanehiro, H | 1 |
Nakajima, Y | 1 |
Park, HK | 1 |
Lee, HW | 1 |
Lee, KS | 1 |
Choi, JS | 1 |
Jeong, BC | 1 |
Kim, HH | 1 |
Jia, Z | 1 |
Wang, N | 1 |
Aoyagi, T | 1 |
Wang, H | 1 |
Liu, H | 1 |
Yang, T | 1 |
Suddek, GM | 1 |
El-Kenawi, AE | 1 |
Abdel-Aziz, A | 1 |
El-Kashef, HA | 1 |
Chen, YH | 1 |
Tarng, DC | 1 |
Benson, P | 1 |
Yudd, M | 1 |
Sims, D | 1 |
Chang, V | 1 |
Srinivas, S | 1 |
Kasimis, B | 1 |
Slørdal, L | 1 |
Samstad, S | 1 |
Bathen, J | 1 |
Spigset, O | 1 |
Audia, P | 1 |
Feinfeld, DA | 1 |
Dubrow, A | 1 |
Winchester, JF | 1 |
Perazella, MA | 1 |
Graham, MG | 1 |
Zhao, SZ | 1 |
Reynolds, MW | 1 |
Lejkowith, J | 1 |
Whelton, A | 1 |
Arellano, FM | 1 |
Deray, G | 1 |
Alkhuja, S | 1 |
Menkel, RA | 1 |
Alwarshetty, M | 1 |
Ibrahimbacha, AM | 1 |
Henao, J | 1 |
Hisamuddin, I | 1 |
Nzerue, CM | 1 |
Vasandani, G | 1 |
Hewan-Lowe, K | 1 |
1 review available for celecoxib and Acute Kidney Injury
Article | Year |
---|---|
COX-2 inhibitors and the kidney.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cy | 2001 |
1 trial available for celecoxib and Acute Kidney Injury
Article | Year |
---|---|
Renal effects of high-dose celecoxib in elderly men with stage D2 prostate carcinoma.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Celecoxib; Cyclooxygenase 2 Inhibitors; Glomerular Fil | 2012 |
16 other studies available for celecoxib and Acute Kidney Injury
Article | Year |
---|---|
Effect of Celecoxib Administration on the Skin of 40-Week-Old Mice.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Mice; Pyrazoles; S | 2022 |
Effect of Caffeic Acid on Ischemia-Reperfusion-Induced Acute Renal Failure in Rats.
Topics: Acute Kidney Injury; Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Blood Urea Nitrogen; Caffei | 2019 |
Evaluation of l-arginine on kidney function and vascular reactivity following ischemic injury in rats: protective effects and potential interactions.
Topics: Acetylcholine; Acute Kidney Injury; Animals; Antioxidants; Aorta; Arginine; Ascorbic Acid; Celecoxib | 2014 |
Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthro | 2016 |
The Administration of Celecoxib as an Analgesic after Liver Resection Is Safe.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Celecoxib; Female; Gast | 2017 |
Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor.
Topics: Acute Kidney Injury; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Express | 2010 |
Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis.
Topics: Acute Kidney Injury; Animals; Arachidonic Acid; Blood Urea Nitrogen; Celecoxib; Cisplatin; Creatinin | 2011 |
Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Celecoxib; Ci | 2011 |
Profound urinary protein loss and acute renal failure caused by cyclooxygenase-2 inhibitor.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxyg | 2011 |
A life-threatening interaction between lithium and celecoxib.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Bipolar Disorder; Celecoxib; Drug Inte | 2003 |
Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.
Topics: Acidosis, Lactic; Acute Disease; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Benzi | 2008 |
Acute renal failure related to high-dose celecoxib.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Dose-Response Relationship, | 2001 |
A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Topics: Acute Kidney Injury; Angiotensin Amide; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxy | 2001 |
[Renal tolerance of selective inhibitors of cyclooxygenase type 2].
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroida | 2001 |
Celecoxib-induced nonoliguric acute renal failure.
Topics: Acute Kidney Injury; Adult; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Female; Hum | 2002 |
Celecoxib-induced acute interstitial nephritis.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibi | 2002 |